BioSig Technologies: Funding, Investors & Team (Oct 2026)
At BioSig, we're working to develop and deliver the advanced signal processing solutions that will unlock the future of bioelectronic medicine, starting with the PURE EP™ System. They built BioSig to achieve this vision – with a strong commitment to research, a world-class leadership team, and a network of expert partners.
BioSig Technologies has raised $6.5M across 2 funding rounds on record, the most recent a Post-IPO Equity of $3.5M announced in Jun 2022.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BioSig Technologies Company Profile and Key Stats
Latest funding round on record: Jun 2022.
BioSig Technologies Funding Rounds
BioSig Technologies raised $3.0M in a Post-IPO Equity announced in Mar 2022.
3 months later, a Post-IPO Equity of $3.5M was announced in Jun 2022.
BioSig Technologies Founders and Leadership Team
No contact details are on record for this team yet.
BioSig Technologies Funding Compared to Other Biotechnology Startups
BioSig Technologies' latest round of $3.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BioSig Technologies in Biotechnology and Westport
Companies Similar to BioSig Technologies
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
BioSig Technologies Funding FAQs
What does BioSig Technologies do?
At BioSig, we're working to develop and deliver the advanced signal processing solutions that will unlock the future of bioelectronic medicine, starting with the PURE EP™ System. They built BioSig to achieve this vision – with a strong commitment to research, a world-class leadership team, and a network of expert partners.
How much funding has BioSig Technologies raised?
BioSig Technologies has raised $6.5M across 2 rounds on record. The most recent is a Post-IPO Equity of $3.5M announced in Jun 2022.
When did BioSig Technologies last raise funding?
BioSig Technologies' most recent funding round on record is a Post-IPO Equity of $3.5M, announced in Jun 2022.
Who is the CEO of BioSig Technologies?
Ken Londoner is listed as CEO at BioSig Technologies.
Where is BioSig Technologies headquartered?
BioSig Technologies is based in Westport, Connecticut, United States.
How many employees does BioSig Technologies have?
BioSig Technologies is in the 51-100 employee band.
How does BioSig Technologies' funding compare to other Biotechnology startups?
BioSig Technologies' latest round of $3.5M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's BioSig Technologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BioSig Technologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.